genuine question about handling that I am slightly embarrassed to ask
Question in the title, detail here: genuine question about handling that I am slightly embarrassed to ask.
Storage conditions came back specific rather than generic when I asked. That told me somebody had actually done stability work.
The three questions to ask before ordering anything from the long tail of a catalogue.
What exactly is it — catalogue number or sequence, not a common name, because several common names map to more than one molecule. How was identity established — mass against theoretical, ideally, rather than a bare purity figure. What are the storage conditions, stated specifically, with a state and a duration attached.
Then two commercial questions that save time: is this a stocked line or made to order, and what is the lead time in writing. All five are one email, and the shape of the reply tells you a great deal before any material moves.
Confirmed the lead time in writing before ordering a made-to-order line. It was longer than the site suggested and entirely reasonable once explained.
Not medical advice, obviously, and nothing here is approved for human use. One person with a spreadsheet.
best — the order this archive was captured in
On the thin testing history in this board, and what to do about it.
Most of the compounds discussed here have a handful of independent results across the entire site, and several have none. That is a fact about how few members have paid for testing, not a judgement about the material.
What follows: buy small, test identity first for anything unusual, and post the result even when it is unremarkable. The vendor source pages are built from exactly these submissions, and the compounds with the thinnest coverage are the ones where one more entry changes the picture most. Research material is not approved for human use, so what this board can usefully build is an analytical record.
Sent an unusual compound to Medutest because nobody on this site had ever posted one. 99.3% against a claimed 99.0%.
Sent an unusual compound to Medutest because nobody on this site had ever posted one.
Adding the practical question — stocked or made to order, and what is the lead time.
Asked for identity confirmation on an unusual line and got a mass spectrum with the theoretical mass alongside. That is the answer I now look for everywhere.
Asked for identity confirmation on an unusual line and got a mass spectrum with the theoretical mass alongside.
This is the rule for anything unusual. Identity before anything else.
Ordered under a name that turned out to cover two different molecules. Nobody’s fault but mine for not asking.
Why purity and net content diverge, and why that is usually honest.
Purity by area percent is a relative measure of what the detector saw. Net peptide content subtracts counterion, water and residual solvent from the powder mass. For some compounds in this catalogue the gap between the two is large.
A vial can therefore be 99% pure and contain considerably less peptide by mass than the label weight suggests, with nothing wrong anywhere. The problem is not the chemistry; it is that people compare a purity figure from one supplier with a net content figure from another and conclude something about both. Ask which number you are being shown, every time.
Small fix — that is net peptide content, not purity. Both are on the certificate and they differ substantially here.
Small fix — that is net peptide content, not purity.
Agreed — and the naming problem is worse than most people here realise.
That result is an area percent from an unspecified method, which is not the same as the identity confirmation being discussed.
For any compound with a thin testing history, identity is the first question. Mass spectrometry against a theoretical mass answers it; an area-percent purity figure does not.
That method was developed for a different compound class and would not resolve the impurities you are asking about.
the same name covers several different molecules in this space
Correction: that name covers two different molecules and the thread has been discussing both as one.